UBS Group AG - INDAPTUS THERAPEUTICS INC ownership

INDAPTUS THERAPEUTICS INC's ticker is and the CUSIP is 45339J105. A total of 18 filers reported holding INDAPTUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INDAPTUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$377
-69.1%
137
-78.6%
0.00%
Q2 2023$1,222
-90.6%
640
-80.6%
0.00%
Q1 2022$13,000
-53.6%
3,294
-33.2%
0.00%
Q4 2021$28,000
+2700.0%
4,932
+3636.4%
0.00%
Q3 2021$1,0001320.00%
Other shareholders
INDAPTUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INVESTMENT HOUSE LLC 95,629$250,0000.02%
Vivaldi Capital Management LP 24,000$63,0000.02%
Stratos Wealth Partners, LTD. 26,832$70,0000.00%
OSAIC HOLDINGS, INC. 19$00.00%
WELLS FARGO & COMPANY/MN 101$00.00%
NORTHERN TRUST CORP 10,296$27,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 6$00.00%
GEODE CAPITAL MANAGEMENT, LLC 52,475$136,0000.00%
STATE STREET CORP 19,473$51,0000.00%
View complete list of INDAPTUS THERAPEUTICS INC shareholders